Latest filing published 26 Jun 2007 for NORTHWEST BIOTHERAPEUTICS INC.
Insider track record
No signal scores available.
Toucan Capital Fund II, LP: trading record in brief
All filings by Toucan Capital Fund II, LP on record concern Northwest Biotherapeutics Inc. In total, 4 filings cover trades dated 22 June 2007.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 26 June 2007 with a transaction in Northwest Biotherapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Toucan Capital Fund II, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,844,968 sharesCommon StockSEC:0001209191-07-039000:1
- 4,287,851 sharesCommon StockSEC:0001209191-07-039000:2
- 2,572,710 sharesCommon StockSEC:0001209191-07-039000:3
- 2,166,667 sharesCommon StockSEC:0001209191-07-039000:0
4 of 4 declarations